Nabors Industries Ltd
$3.00B- Market cap
- $1.45B
- Debt
- +$2.49B
- Cash
- −$940.74M
Capital structure 37% equity / 63% debt · EV / Revenue 0.94x · EV / EBITDA 2.30x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: NBR stock price vs ANIK: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ANIK's multiple
Needs ANIK P/E.
Implied fair value · at NBR's multiple
Needs EPS (TTM) is negative, NBR P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: NBR FY 2025 (ended Dec 31, 2025) · ANIK FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 37% equity / 63% debt · EV / Revenue 0.94x · EV / EBITDA 2.30x
Capital structure 100% equity / -0% debt · EV / Revenue 1.75x
NBR carries the larger enterprise value at $3.00B against $197.18M; NBR trades on the lower EV / Revenue multiple (0.94x vs 1.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
NABORS INDUSTRIES LTD · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Anika Therapeutics, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
4.22x
-0.00x
Net debt / EBITDA
Leverage against operating earnings
1.19x
34.65x
Cash and equivalents
Liquid reserves on the balance sheet
$940.74M
$81.17M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Helmerich & Payne, Inc.
NBR vs HP
Transocean Ltd.
NBR vs RIG
HELIX ENERGY SOLUTIONS GROUP INC
NBR vs HLX
PATTERSON UTI ENERGY INC
NBR vs PTEN
ZIMMER BIOMET HOLDINGS, INC.
NBR vs ZBH
STRYKER CORP
NBR vs SYK
BECTON DICKINSON & CO
NBR vs BDX
INTEGRA LIFESCIENCES HOLDINGS CORP
NBR vs IART
$2.49B
-$149.00K
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.